|
Volumn 30, Issue 7, 2012, Pages 759-760
|
Reply to M. Moroni and U. De Giorgi et al
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
DRUG DOSE REGIMEN;
DRUG MEGADOSE;
DRUG SAFETY;
HUMAN;
LETTER;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TRIPLE NEGATIVE BREAST CANCER;
|
EID: 84857519149
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2011.39.7588 Document Type: Letter |
Times cited : (2)
|
References (4)
|